Skip to content

Magnesium sulfate as an adjunct to levobupivacaine in rectus sheath block for colorectal surgery: a randomized controlled study

Magnesium sulfate as an adjunct to levobupivacaine in rectus sheath block for colorectal surgery: a randomized controlled study

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000376347
Enrollment
60
Registered
2026-03-25
Start date
2026-04-14
Completion date
2026-05-18
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary objective of our study is to assess the effect of adding magnesium sulfate to the local anesthetic levobupivacaine in the rectus sheath block on the duration of the blockade. We hypothesize that the addition of magnesium sulfate will increase the duration of the block. The purpose of our research is to determine the quality and duration of postoperative analgesia after bilateral rectus sheath block (RSB) in colorectal surgeries with a midline laparotomy approach, as well as the total postoperative opioid consumption over 24 hours.

Interventions

After induction into general anesthesia, an experienced anesthesiologist will perform a bilateral rectus sheath block under ultrasound guidance. The rectus sheath block will include 30 ml of 0.25% Levobupivacaine with an addition of 500mg magnesium sulfate in total, with half the dose applied to one side and the other half to the opposite side. Adherence to intervention will be assessed through review of operative medical notes

Sponsors

University Hospital Sestre Milosrdnice
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Consenting patients over the age of 18 undergoing elective colorectal surgery.

Exclusion criteria

Exclusion criteria are: patients undergoing emergency surgery, ASA greater than 3, reoperation, history of opioid abuse, chronic pain syndromes, infection at the site where the block is performed, history of allergy to local anesthetics, coagulation disorders and patient withdrawing consent.

Outcome results

None listed

Source: ANZCTR · Data processed: Apr 4, 2026